glp-1 food industry news today Weight loss drug patients spend less on restaurants, takeout: survey Protein-Rich Frozen Meals Gain Popularity

For postmenopausal women, GLP-1s can support insulin sensitivity, reduce visceral fat, and lower cardiovascular risk

Glow Brighter

Subgroup analyses revealed important differences based on comparator drugs: GLP-1RAs demonstrated greater effectiveness than SGLT2 inhibitors in preventing MALOs (IRR: 0.93, 95%CI: 0.87-0.99, P = 0.043), than DPP-4 inhibitors in preventing hepatic decompensation events (IRR: 0.74, 95%CI: 0.66-0.83, P = 0.003), and than insulin therapy in averting HCC development (IRR: 0.32, 95%CI: 0.13-0.80, P = 0.033) [64]

adults is currently taking a GLP-1 drug like Ozempic or Zepbound, according to the KFF Health Tracking Poll conducted from Oct